From a prognostic point of view, significant FN1 overexpression (p < 0.05) was confirmed in the HR-NB compared to LR-NB patients, while MYH9 and LTBP1 did not report any significant modulation (Figure 7B). This evidence concerns the gene MYH9 and neuroblastoma.